These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12700344)

  • 1. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia.
    Hovingh GK; Van Wijland MJ; Brownlie A; Bisoendial RJ; Hayden MR; Kastelein JJ; Groen AK
    J Lipid Res; 2003 Jun; 44(6):1251-5. PubMed ID: 12700344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
    Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
    Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.
    Clee SM; Kastelein JJ; van Dam M; Marcil M; Roomp K; Zwarts KY; Collins JA; Roelants R; Tamasawa N; Stulc T; Suda T; Ceska R; Boucher B; Rondeau C; DeSouich C; Brooks-Wilson A; Molhuizen HO; Frohlich J; Genest J; Hayden MR
    J Clin Invest; 2000 Nov; 106(10):1263-70. PubMed ID: 11086027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency.
    Marcil M; Bissonnette R; Vincent J; Krimbou L; Genest J
    Circulation; 2003 Mar; 107(10):1366-71. PubMed ID: 12642355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts.
    Haidar B; Denis M; Krimbou L; Marcil M; Genest J
    J Lipid Res; 2002 Dec; 43(12):2087-94. PubMed ID: 12454270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease.
    Choi HY; Karten B; Chan T; Vance JE; Greer WL; Heidenreich RA; Garver WS; Francis GA
    J Biol Chem; 2003 Aug; 278(35):32569-77. PubMed ID: 12813037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium taurocholate-dependent lipid efflux by ABCA1: effects of W590S mutation on lipid translocation and apolipoprotein A-I dissociation.
    Nagao K; Zhao Y; Takahashi K; Kimura Y; Ueda K
    J Lipid Res; 2009 Jun; 50(6):1165-72. PubMed ID: 19202195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
    Neufeld EB; Stonik JA; Demosky SJ; Knapper CL; Combs CA; Cooney A; Comly M; Dwyer N; Blanchette-Mackie J; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2004 Apr; 279(15):15571-8. PubMed ID: 14747463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
    Timmins JM; Lee JY; Boudyguina E; Kluckman KD; Brunham LR; Mulya A; Gebre AK; Coutinho JM; Colvin PL; Smith TL; Hayden MR; Maeda N; Parks JS
    J Clin Invest; 2005 May; 115(5):1333-42. PubMed ID: 15841208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities.
    Fitzgerald ML; Okuhira K; Short GF; Manning JJ; Bell SA; Freeman MW
    J Biol Chem; 2004 Nov; 279(46):48477-85. PubMed ID: 15347662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein.
    Wang N; Silver DL; Thiele C; Tall AR
    J Biol Chem; 2001 Jun; 276(26):23742-7. PubMed ID: 11309399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
    Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
    Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.
    Favari E; Calabresi L; Adorni MP; Jessup W; Simonelli S; Franceschini G; Bernini F
    Biochemistry; 2009 Nov; 48(46):11067-74. PubMed ID: 19839639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL.
    Soro-Paavonen A; Naukkarinen J; Lee-Rueckert M; Watanabe H; Rantala E; Soderlund S; Hiukka A; Kovanen PT; Jauhiainen M; Peltonen L; Taskinen MR
    J Lipid Res; 2007 Jun; 48(6):1409-16. PubMed ID: 17372331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.
    Brousseau ME; Eberhart GP; Dupuis J; Asztalos BF; Goldkamp AL; Schaefer EJ; Freeman MW
    J Lipid Res; 2000 Jul; 41(7):1125-35. PubMed ID: 10884295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.
    Slatter TL; Williams MJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Morison IM; McCormick SP
    Atherosclerosis; 2006 Aug; 187(2):393-400. PubMed ID: 16225879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of apolipoprotein A-I/ATP binding cassette transporter A1-mediated cholesterol and phospholipid release.
    Yamauchi Y; Abe-Dohmae S; Yokoyama S
    Biochim Biophys Acta; 2002 Nov; 1585(1):1-10. PubMed ID: 12457709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-binding cassette transporter AI and its role in HDL formation.
    Lee JY; Parks JS
    Curr Opin Lipidol; 2005 Feb; 16(1):19-25. PubMed ID: 15650559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease.
    Uehara Y; Tsuboi Y; Zhang B; Miura S; Baba Y; Higuchi MA; Yamada T; Rye KA; Saku K
    Atherosclerosis; 2008 Mar; 197(1):283-9. PubMed ID: 17560579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.